Kyle Bake
Principal Scientist, Chemistry, Manufacturing, Controls, Analytical Development, Stylus Medicine
Kyle Bake is a Principal Scientist at Stylus Medicine specializing in analytical development, nanoparticle formulation, and CMC strategy for genetic medicines. He brings extensive experience spanning industry and academic research, with a background in process development, stability studies, and analytical chemistry. His work focuses on enabling scalable, high-quality therapeutic development.
Seminars
Wednesday 18th November 2026
Panel Discussion: Have We Defined the Right Critical Quality Attributes (CQAs) for LNPs?
12:00 pm
- If you could only release an LNP product with five assays, what would they be?
- What are the most over-measured attributes in LNP development today?
- Should every measured attribute eventually be linked to biological function?
